Solid forms of N- (4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(tri fluoromethyl) phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dih ydroquinoline-3-carboxamide

Details for Australian Patent Application No. 2009308241 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Zhang, Beili; Krawiec, Mariusz; Botfield, Martyn; Grootenhuis, Peter D. J.; Van Goor, Fredrick

Agent Cullens

Pub. Number AU-A-2009308241

PCT Pub. Number WO2010/048573

Priority 61/107,813 23.10.08 US

Filing date 23 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 215/56 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048573 Priority application(s): WO2010/048573

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308244-Method of synthesizing macrolide compounds

2009308236-Modified photosynthetic microorganisms for producing triglycerides